Ranjith Siva, Thomas Jacob Akhil, Augustine Paul, K Chandramohan, Muralee Madhu, Joseph John, Radhakrishnan Neelima, Krishna Km Jagathnath
Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Thiruvananthapuram, IND.
Surgical Oncology, M. G. George Muthoot Cancer Centre, Kozhencherry, IND.
Cureus. 2025 Jun 28;17(6):e86938. doi: 10.7759/cureus.86938. eCollection 2025 Jun.
Introduction Radical cystectomy (RC) with pelvic lymph node dissection and urinary diversion is the preferred treatment for non-metastatic muscle invasive bladder cancer (MIBC) and for some high-risk non-muscle invasive bladder cancer (NMIBC), in patients fit for major surgery. Primary objective The primary objective of this study is to estimate the overall survival (OS) of patients with MIBC who have undergone RC. Secondary objective The secondary objectives are to estimate the disease-free survival (DFS) of patients with MIBC following RC and to determine factors that influence OS and DFS in this population. Methodology This was an ambispective study of patients who underwent RC for carcinoma of the urinary bladder between 1st January 2010 and 30th April 2022. Clinicopathological data were obtained from the patients' clinical records. Results The study included a total of 106 patients, with a mean age of 59.35 years. Of these, 55.88% had received neoadjuvant chemotherapy (NACT), and 13 patients (11.7%) underwent salvage cystectomy. Only five patients received intravesical chemotherapy instillation following transurethral resection of bladder tumor (TURBT). RC was performed via laparotomy in 82 patients, while 24 patients underwent a laparoscopic approach. The mean hospital stay was five days. Ninety-eight patients had Clavien-Dindo grade II morbidity. There were no intra-hospital or 30-day mortalities. The histopathologic report showed that 21 patients had achieved pathological complete response (PCR). A total of 96 patients were kept on follow-up, of whom 32 patients had recurrence. Median DFS was 145 months, and median OS was 118 months. PCR was found to be significantly associated with improved DFS. Smoking was found to be a significant predictor of OS on multivariate analysis. Conclusions Although NACT did not reach statistical significance as an independent predictor of survival, it contributed to the achievement of PCR, which was predictive of DFS and OS. Hence, NACT should be pursued wherever feasible. Further, this study shows the importance of smoking cessation, as current or recent smoking was found to have a negative impact on survival among patients with bladder cancer.
引言
根治性膀胱切除术(RC)联合盆腔淋巴结清扫术及尿流改道术是适合进行大手术的非转移性肌层浸润性膀胱癌(MIBC)及部分高危非肌层浸润性膀胱癌(NMIBC)的首选治疗方法。
主要目标
本研究的主要目标是评估接受RC治疗的MIBC患者的总生存期(OS)。
次要目标
次要目标是评估RC术后MIBC患者的无病生存期(DFS),并确定影响该人群OS和DFS的因素。
方法
这是一项对2010年1月1日至2022年4月30日期间因膀胱癌接受RC治疗的患者进行的前瞻性研究。临床病理数据来自患者的临床记录。
结果
该研究共纳入106例患者,平均年龄59.35岁。其中,55.88%的患者接受了新辅助化疗(NACT),13例患者(11.7%)接受了挽救性膀胱切除术。只有5例患者在经尿道膀胱肿瘤切除术(TURBT)后接受了膀胱内化疗灌注。82例患者通过开腹手术进行RC,24例患者采用腹腔镜手术。平均住院时间为5天。98例患者出现Clavien-Dindo II级并发症。无院内死亡或30天内死亡病例。组织病理学报告显示,21例患者达到病理完全缓解(PCR)。共有96例患者接受随访,其中32例患者复发。中位DFS为145个月,中位OS为118个月。发现PCR与DFS改善显著相关。多因素分析显示,吸烟是OS的显著预测因素。
结论
尽管NACT作为生存的独立预测因素未达到统计学意义,但它有助于实现PCR,而PCR可预测DFS和OS。因此,应在可行的情况下采用NACT。此外,本研究表明戒烟的重要性,因为目前或近期吸烟被发现对膀胱癌患者的生存有负面影响。